Vernakalant versus ibutilide for immediate conversion of recent-onset atrial fibrillation

Background: The pharmacological cardioversion of recent-onset atrial fibrillation (AF) is a challenge for the clinician. The aim of the study was to compare the efficacy, the safety, and the overall cost of intravenous (iv) administration of vernakalant, which is a relatively new atrial-selective an...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Hippokratia
Asıl Yazarlar: Vogiatzis, I, Papavasiliou, E, Dapcevitch, I, Pittas, S, Koulouris, E
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: SOCIETY OF "FRIENDS OF HIPPOKRATIA JOURNAL" 2017
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6239091/
https://ncbi.nlm.nih.gov/pubmed/30455558
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller